Cambridge, MA
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.
orbitaltx.comThese are collections Orbital Therapeutics is a part of. Click on the collection name to view similar companies.
Series A
$270,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Orbital Therapeutics.